| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5685294 | American Journal of Kidney Diseases | 2017 | 11 Pages |
Abstract
In patients undergoing maintenance hemodialysis, daily supplementation with 1,200Â mg of CoQ10 is safe and results in a reduction in plasma concentrations of F2-isoprostanes, a marker of oxidative stress. Future studies are needed to determine whether CoQ10 supplementation improves clinical outcomes for patients undergoing maintenance hemodialysis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Matthew B. MD, Catherine K. PharmD, PhD, MPH, Cassianne PhD, Brian R. BS, John BS, Denise BS, Lori BA, Danny D. PhD, T. Alp MD, Jonathan MD,